Retour
40
Fourchette du Jour
193,81 €
197,03 €
Fourchette 52 Semaines
157,20 €
213,50 €
Volume
384 942
Moyenne 50J / 200J
195,42 €
/
183,46 €
Clôture Précédente
195,60 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (627 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 22,0 | 0,3 |
| P/B | 3,0 | 2,9 |
| ROE % | 14,2 | 3,7 |
| Net Margin % | 9,0 | 3,8 |
| Rev Growth 5Y % | 0,6 | 10,0 |
| D/E | 1,0 | 0,2 |
Objectif de Cours des Analystes
Hold
215,10 €
+9.7%
Low: 200,00 €
High: 235,00 €
P/E Prévisionnel
18,4
BPA Prévisionnel
10,64 €
Croissance BPA (est.)
+0,0%
CA Est.
12 B
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2029 |
13,89 €
13,50 € – 14,19 €
|
13 B | 2 |
| FY2028 |
12,49 €
11,82 € – 13,50 €
|
13 B | 7 |
| FY2027 |
11,47 €
11,22 € – 11,85 €
|
12 B | 12 |
Points Clés
Revenue grew 0,57% annually over 5 years — modest growth
ROE of 14,22% — decent returns on equity
Generating 1,36B in free cash flow
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 11,21%
Cash machine — converts 137,00% of earnings into free cash flow
Capital efficient — spends only 4,78% of revenue on capex
Croissance
Revenue Growth (5Y)
0,57%
Revenue (1Y)11,78%
Earnings (1Y)13,89%
FCF Growth (3Y)25,42%
Qualité
Return on Equity
14,22%
ROIC8,53%
Net Margin8,99%
Op. Margin14,53%
Sécurité
Debt / Equity
0,96
Current Ratio1,04
Interest Coverage6,07
Valorisation
P/E Ratio
21,99
P/B Ratio3,04
EV/EBITDA17,66
Dividend Yield0,02%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 11,78% | Revenue Growth (3Y) | 9,21% |
| Earnings Growth (1Y) | 13,89% | Earnings Growth (3Y) | 7,78% |
| Revenue Growth (5Y) | 0,57% | Earnings Growth (5Y) | -16,03% |
| Profitability | |||
| Revenue (TTM) | 11,04B | Net Income (TTM) | 992,00M |
| ROE | 14,22% | ROA | 6,11% |
| Gross Margin | 31,93% | Operating Margin | 14,53% |
| Net Margin | 8,99% | Free Cash Flow (TTM) | 1,36B |
| ROIC | 8,53% | FCF Growth (3Y) | 25,42% |
| Safety | |||
| Debt / Equity | 0,96 | Current Ratio | 1,04 |
| Interest Coverage | 6,07 | Dividend Yield | 0,02% |
| Valuation | |||
| P/E Ratio | 21,99 | P/B Ratio | 3,04 |
| P/S Ratio | 1,98 | PEG Ratio | 1,42 |
| EV/EBITDA | 17,66 | Dividend Yield | 0,02% |
| Market Cap | 21,81B | Enterprise Value | 28,31B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 11,04B | 9,87B | 9,25B | 9,88B | 10,79B |
| Net Income | 992,00M | 871,00M | 854,00M | 946,00M | 2,00B |
| EPS (Diluted) | 8,75 | 7,69 | 7,52 | 7,98 | 15,53 |
| Gross Profit | 3,52B | 3,24B | 3,07B | 3,43B | 4,21B |
| Operating Income | 1,60B | 1,35B | 1,26B | 1,43B | 2,38B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 16,23B | 16,15B | 14,02B | 12,84B | 13,61B |
| Total Liabilities | 8,94B | 9,26B | 7,60B | 6,83B | 7,05B |
| Shareholders' Equity | 7,17B | 6,78B | 6,31B | 5,89B | 6,44B |
| Total Debt | 6,92B | 7,09B | 5,50B | 4,71B | 4,77B |
| Cash & Equivalents | 420,00M | 549,00M | 686,00M | 315,00M | 872,00M |
| Current Assets | 2,38B | 2,39B | 2,37B | 1,90B | 2,74B |
| Current Liabilities | 2,28B | 2,17B | 1,82B | 1,55B | 1,75B |
Scores de Stratégies
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Custom
Cash Flow Compounder
#614 of 1052
Activité Récente
Entré
Cash Flow Compounder
Mar 24, 2026